Editorial: Advances in Heart Transplantation

Front Immunol. 2022 Jun 27:13:960800. doi: 10.3389/fimmu.2022.960800. eCollection 2022.

Guido Moll¹, Zhenhua Dai^{2

3

4

5}, Niels Olsen Saraiva Câmara^{6

7}

¹ Berlin Institute of Health (BIH) Center for Regenerative Therapies (BCRT) and Berlin-Brandenburg School for Regenerative Therapies (BSRT), Berlin Institute of Health (BIH) at the Charité Universitätsmedizin Berlin, corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
² State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
³ Section of Immunology and Joint Immunology Program, Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou, China.
⁴ Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou, China.
⁵ Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Diseases, Guangzhou University of Chinese Medicine, Guangzhou, China.
⁶ Department of Immunology, Institute of Biomedical Science, University of São Paulo, São Paulo, Brazil.
⁷ Nephrology Division, Department of Medicine, Federal University of São Paulo, São Paulo, Brazil.

No abstract available

Keywords: biomarkers/new targets; heart failure; heart transplantation; immune tolerance; transplant rejection.

Publication types